IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
1.580
+0.010 (0.64%)
At close: Apr 2, 2025, 4:00 PM
1.530
-0.050 (-3.16%)
After-hours: Apr 2, 2025, 6:21 PM EDT
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands.
The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
IM Cannabis Corp.
| Country | Israel |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: Kibbutz Glil Yam, Central District Tel Aviv, 4690500 Israel | |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| CIK Code | 0001792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q3070 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Chairman and Chief Executive Officer |
| Uri Birenberg | Chief Financial Officer |
| Anna Taranko | Director Investor and Public Relations |
| Advocate Michal Lebovitz Nissimov | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 31, 2025 | 6-K | Report of foreign issuer |
| Mar 31, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Mar 20, 2025 | 6-K | Report of foreign issuer |
| Mar 5, 2025 | 6-K | Report of foreign issuer |
| Feb 5, 2025 | 6-K | Report of foreign issuer |
| Jan 17, 2025 | 6-K | Report of foreign issuer |
| Jan 6, 2025 | 6-K | Report of foreign issuer |
| Dec 4, 2024 | 6-K | Report of foreign issuer |
| Nov 20, 2024 | D | Notice of Exempt Offering of Securities |
| Nov 14, 2024 | 6-K | Report of foreign issuer |